- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Comdisco lands $25 million lease
The U.K. affiliate of medicalequipment lessor Comdisco Medical Equipment Group has inked adeal to supply a Scottish hospital with $25 million in high-technologymedical equipment. Comdisco said the deal is believed to be oneof the largest leases of
The U.K. affiliate of medicalequipment lessor Comdisco Medical Equipment Group has inked adeal to supply a Scottish hospital with $25 million in high-technologymedical equipment. Comdisco said the deal is believed to be oneof the largest leases of high-tech equipment to a health-careprovider in the world.
Comdisco U.K. signed the deal with Health Care International,which has built a 260-bed tertiary care hospital near Glasgow,Scotland. The technology under lease includes medical imagingequipment, computers, telecommunications equipment and cardiacmonitoring devices.
The lease highlights Comdisco's increased focus on the internationalmarket, according to the company. Another sign of that focus camethis month, when Comdisco shipped a refurbished cardiac catheterizationlab to a Moscow hospital. The unit is one of only six in Russiaand the second supplied by Comdisco, according to the company.Comdisco supplied the first lab last year to a medical facilityin central Siberia.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
